Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Titel:
Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Auteur:
Safra, Tamar Kaufman, Bella Kadouri, Luna Efrat (Ben-Baruch), Noa Ryvo, Larisa Nisenbaum, Bella Evron, Ella Yerushalmi, Rinat